Report Detail

Pharma & Healthcare Global Delirium Treatment Drugs Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4677965
  • |
  • 26 February, 2026
  • |
  • Global
  • |
  • 120 Pages
  • |
  • GIR
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Delirium Treatment Drugs market size was valued at US$ 322 million in 2025 and is forecast to a readjusted size of US$ 487 million by 2032 with a CAGR of 6.2% during review period.
This report is a detailed and comprehensive analysis for global Delirium Treatment Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Delirium Treatment Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Delirium Treatment Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Delirium Treatment Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Delirium Treatment Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Delirium Treatment Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Delirium Treatment Drugs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mylan N.V., Pfizer Inc., Novartis AG, Gala BioPharma Ltd., Teva pharmaceuticals, Dr Franz Kohler Chemie GmbH, Bristol-Myers Squibb, Regenstrief Institute Inc, Fraser Health, Otsuka Pharmaceutical Co. Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Delirium Treatment Drugs market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Oral
Injection
Others
Market segment by Application
Hospitals
Clinics
Major players covered
Mylan N.V.
Pfizer Inc.
Novartis AG
Gala BioPharma Ltd.
Teva pharmaceuticals
Dr Franz Kohler Chemie GmbH
Bristol-Myers Squibb
Regenstrief Institute Inc
Fraser Health
Otsuka Pharmaceutical Co. Ltd.
Zydus Cadila
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Delirium Treatment Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Delirium Treatment Drugs, with price, sales quantity, revenue, and global market share of Delirium Treatment Drugs from 2021 to 2026.
Chapter 3, the Delirium Treatment Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Delirium Treatment Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Delirium Treatment Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Delirium Treatment Drugs.
Chapter 14 and 15, to describe Delirium Treatment Drugs sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Delirium Treatment Drugs Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Oral
    • 1.3.3 Injection
    • 1.3.4 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Delirium Treatment Drugs Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospitals
    • 1.4.3 Clinics
  • 1.5 Global Delirium Treatment Drugs Market Size & Forecast
    • 1.5.1 Global Delirium Treatment Drugs Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Delirium Treatment Drugs Sales Quantity (2021-2032)
    • 1.5.3 Global Delirium Treatment Drugs Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Mylan N.V.
    • 2.1.1 Mylan N.V. Details
    • 2.1.2 Mylan N.V. Major Business
    • 2.1.3 Mylan N.V. Delirium Treatment Drugs Product and Services
    • 2.1.4 Mylan N.V. Delirium Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Mylan N.V. Recent Developments/Updates
  • 2.2 Pfizer Inc.
    • 2.2.1 Pfizer Inc. Details
    • 2.2.2 Pfizer Inc. Major Business
    • 2.2.3 Pfizer Inc. Delirium Treatment Drugs Product and Services
    • 2.2.4 Pfizer Inc. Delirium Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Pfizer Inc. Recent Developments/Updates
  • 2.3 Novartis AG
    • 2.3.1 Novartis AG Details
    • 2.3.2 Novartis AG Major Business
    • 2.3.3 Novartis AG Delirium Treatment Drugs Product and Services
    • 2.3.4 Novartis AG Delirium Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Novartis AG Recent Developments/Updates
  • 2.4 Gala BioPharma Ltd.
    • 2.4.1 Gala BioPharma Ltd. Details
    • 2.4.2 Gala BioPharma Ltd. Major Business
    • 2.4.3 Gala BioPharma Ltd. Delirium Treatment Drugs Product and Services
    • 2.4.4 Gala BioPharma Ltd. Delirium Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Gala BioPharma Ltd. Recent Developments/Updates
  • 2.5 Teva pharmaceuticals
    • 2.5.1 Teva pharmaceuticals Details
    • 2.5.2 Teva pharmaceuticals Major Business
    • 2.5.3 Teva pharmaceuticals Delirium Treatment Drugs Product and Services
    • 2.5.4 Teva pharmaceuticals Delirium Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Teva pharmaceuticals Recent Developments/Updates
  • 2.6 Dr Franz Kohler Chemie GmbH
    • 2.6.1 Dr Franz Kohler Chemie GmbH Details
    • 2.6.2 Dr Franz Kohler Chemie GmbH Major Business
    • 2.6.3 Dr Franz Kohler Chemie GmbH Delirium Treatment Drugs Product and Services
    • 2.6.4 Dr Franz Kohler Chemie GmbH Delirium Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Dr Franz Kohler Chemie GmbH Recent Developments/Updates
  • 2.7 Bristol-Myers Squibb
    • 2.7.1 Bristol-Myers Squibb Details
    • 2.7.2 Bristol-Myers Squibb Major Business
    • 2.7.3 Bristol-Myers Squibb Delirium Treatment Drugs Product and Services
    • 2.7.4 Bristol-Myers Squibb Delirium Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Bristol-Myers Squibb Recent Developments/Updates
  • 2.8 Regenstrief Institute Inc
    • 2.8.1 Regenstrief Institute Inc Details
    • 2.8.2 Regenstrief Institute Inc Major Business
    • 2.8.3 Regenstrief Institute Inc Delirium Treatment Drugs Product and Services
    • 2.8.4 Regenstrief Institute Inc Delirium Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Regenstrief Institute Inc Recent Developments/Updates
  • 2.9 Fraser Health
    • 2.9.1 Fraser Health Details
    • 2.9.2 Fraser Health Major Business
    • 2.9.3 Fraser Health Delirium Treatment Drugs Product and Services
    • 2.9.4 Fraser Health Delirium Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Fraser Health Recent Developments/Updates
  • 2.10 Otsuka Pharmaceutical Co. Ltd.
    • 2.10.1 Otsuka Pharmaceutical Co. Ltd. Details
    • 2.10.2 Otsuka Pharmaceutical Co. Ltd. Major Business
    • 2.10.3 Otsuka Pharmaceutical Co. Ltd. Delirium Treatment Drugs Product and Services
    • 2.10.4 Otsuka Pharmaceutical Co. Ltd. Delirium Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Otsuka Pharmaceutical Co. Ltd. Recent Developments/Updates
  • 2.11 Zydus Cadila
    • 2.11.1 Zydus Cadila Details
    • 2.11.2 Zydus Cadila Major Business
    • 2.11.3 Zydus Cadila Delirium Treatment Drugs Product and Services
    • 2.11.4 Zydus Cadila Delirium Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Zydus Cadila Recent Developments/Updates

3 Competitive Environment: Delirium Treatment Drugs by Manufacturer

  • 3.1 Global Delirium Treatment Drugs Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Delirium Treatment Drugs Revenue by Manufacturer (2021-2026)
  • 3.3 Global Delirium Treatment Drugs Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Delirium Treatment Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Delirium Treatment Drugs Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Delirium Treatment Drugs Manufacturer Market Share in 2025
  • 3.5 Delirium Treatment Drugs Market: Overall Company Footprint Analysis
    • 3.5.1 Delirium Treatment Drugs Market: Region Footprint
    • 3.5.2 Delirium Treatment Drugs Market: Company Product Type Footprint
    • 3.5.3 Delirium Treatment Drugs Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Delirium Treatment Drugs Market Size by Region
    • 4.1.1 Global Delirium Treatment Drugs Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Delirium Treatment Drugs Consumption Value by Region (2021-2032)
    • 4.1.3 Global Delirium Treatment Drugs Average Price by Region (2021-2032)
  • 4.2 North America Delirium Treatment Drugs Consumption Value (2021-2032)
  • 4.3 Europe Delirium Treatment Drugs Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Delirium Treatment Drugs Consumption Value (2021-2032)
  • 4.5 South America Delirium Treatment Drugs Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Delirium Treatment Drugs Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Delirium Treatment Drugs Sales Quantity by Type (2021-2032)
  • 5.2 Global Delirium Treatment Drugs Consumption Value by Type (2021-2032)
  • 5.3 Global Delirium Treatment Drugs Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Delirium Treatment Drugs Sales Quantity by Application (2021-2032)
  • 6.2 Global Delirium Treatment Drugs Consumption Value by Application (2021-2032)
  • 6.3 Global Delirium Treatment Drugs Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Delirium Treatment Drugs Sales Quantity by Type (2021-2032)
  • 7.2 North America Delirium Treatment Drugs Sales Quantity by Application (2021-2032)
  • 7.3 North America Delirium Treatment Drugs Market Size by Country
    • 7.3.1 North America Delirium Treatment Drugs Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Delirium Treatment Drugs Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Delirium Treatment Drugs Sales Quantity by Type (2021-2032)
  • 8.2 Europe Delirium Treatment Drugs Sales Quantity by Application (2021-2032)
  • 8.3 Europe Delirium Treatment Drugs Market Size by Country
    • 8.3.1 Europe Delirium Treatment Drugs Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Delirium Treatment Drugs Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Delirium Treatment Drugs Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Delirium Treatment Drugs Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Delirium Treatment Drugs Market Size by Region
    • 9.3.1 Asia-Pacific Delirium Treatment Drugs Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Delirium Treatment Drugs Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Delirium Treatment Drugs Sales Quantity by Type (2021-2032)
  • 10.2 South America Delirium Treatment Drugs Sales Quantity by Application (2021-2032)
  • 10.3 South America Delirium Treatment Drugs Market Size by Country
    • 10.3.1 South America Delirium Treatment Drugs Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Delirium Treatment Drugs Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Delirium Treatment Drugs Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Delirium Treatment Drugs Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Delirium Treatment Drugs Market Size by Country
    • 11.3.1 Middle East & Africa Delirium Treatment Drugs Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Delirium Treatment Drugs Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Delirium Treatment Drugs Market Drivers
  • 12.2 Delirium Treatment Drugs Market Restraints
  • 12.3 Delirium Treatment Drugs Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Delirium Treatment Drugs and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Delirium Treatment Drugs
  • 13.3 Delirium Treatment Drugs Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Delirium Treatment Drugs Typical Distributors
  • 14.3 Delirium Treatment Drugs Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Delirium Treatment Drugs. Industry analysis & Market Report on Delirium Treatment Drugs is a syndicated market report, published as Global Delirium Treatment Drugs Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Delirium Treatment Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report